4//SEC Filing
He Wei-Wu 4
Accession 0001104659-20-040338
CIK 0000895051other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:01 PM ET
Size
7.1 KB
Accession
0001104659-20-040338
Insider Transaction Report
Form 4
He Wei-Wu
Director
Transactions
- Purchase
Common Stock
2020-03-27$2.08/sh+6,880$14,310→ 1,358,900 total
Holdings
- 441,072(indirect: See Footnote)
Common Stock
- 6,332,347(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The shares are held indirectly in the name of ETP Global Fund LP, a limited partnership of which the Reporting Person is the managing member of the general partner. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest therein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purposes.
- [F2]The shares are held indirectly in the name of Emerging Technology Partners, LLC, an LLC entity of which the Reporting Person is the managing member. The Reporting Person disclaims beneficial ownership over any shares held indirectly, except to the extent of his pecuniary interest thein and his filing is not an admission that the Reporting Person is the beneficial owner of these shares for the purposes of Section 16 or any other purposes.
Documents
Issuer
CASI Pharmaceuticals, Inc.
CIK 0000895051
Entity typeother
Related Parties
1- filerCIK 0001542073
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:01 PM ET
- Size
- 7.1 KB